News

Deal Announcements

Agile Therapeutics Secures Venture Capital Debt

Monday, January 7, 2013 5:56:00 AM PDT | VentureDeal
Princeton, New Jersey  --  Pharmaceutical company Agile Therapeutics has garnered $15 million in new venture capital debt financing.

Agile is developing contraceptive pharmaceutical products utilizing its proprietary transdermal drug delivery technology.

Oxford Finance made the financing facility.

Agile will use the additional funding to advance its product pipeline prepare for commercialization activities.

Email Page  Email Page | Print Page Print Page

Free Trial

Want unlimited access to the complete database with thousands of technology companies, VCs and transactions for only $25 per month?

Start your Free 14 Day Trial now – no obligation or credit card required.

Free 14 day trial. No Obligation. Click to Register.
Venturedeal Twitter Venturedeal Facebook Venturedeal Linkedin


PCI - Level1